PowerPoint Presentation: Patient Comprehension of Antiretroviral Drug Resistance: Implications for Treatment and Clinical Practice

Patient Comprehension of Antiretroviral Drug Resistance: Implications for Treatment and Clinical Practice” (PowerPoint Presentation)

Author: Catherine Sarai Racey

Objective:

To determine the current level of Knowledge of HIV drug resistance in a cohort of HIV+ people on HAART

  • Identify predictive factors for comprehension
  • Identify areas of focus for improving comprehension
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025